Faraz Ali insider trades

Open-market stock purchases and sales by Faraz Ali, Chief Executive Officer at Tenaya Therapeutics, Inc, from SEC Form 4 filings since Mar 2, 2016.

Recent trades

DateStockTradeValue
Sep 10, 2026TNYA Tenaya Therapeutics, IncBought (not open market)—
Sep 10, 2026TNYA Tenaya Therapeutics, IncBought (not open market)—
Aug 17, 2026TNYA Tenaya Therapeutics, IncSold$4.1K
Aug 17, 2026TNYA Tenaya Therapeutics, IncSold$2.8K
Aug 17, 2026TNYA Tenaya Therapeutics, IncSold$3.6K
Aug 17, 2026TNYA Tenaya Therapeutics, IncSold$5.3K
May 18, 2026TNYA Tenaya Therapeutics, IncSold$2.7K
Feb 17, 2026TNYA Tenaya Therapeutics, IncSold$3.8K
Feb 17, 2026TNYA Tenaya Therapeutics, IncSold$2.6K
Feb 17, 2026TNYA Tenaya Therapeutics, IncSold$3.2K
Feb 3, 2026TNYA Tenaya Therapeutics, IncBought (not open market)—
Feb 3, 2026TNYA Tenaya Therapeutics, IncBought (not open market)—
Nov 17, 2025TNYA Tenaya Therapeutics, IncSold$4.2K

Companies traded

  • TNYA Tenaya Therapeutics, Inc: 19 sales, last Sep 10, 2026
  • RGNX REGENXBIO Inc: other filings, last Jan 4, 2017

Get free alerts when Faraz Ali files a new trade →